Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • current treatmentRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • current treatmentRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Not Applicable
2
50%
Phase 3
1
25%
Phase 4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

NCT03666351
completednot_applicable

Norwegian Capture the Fracture Initiative

NCT02536898
unknownnot_applicable

Impact of a Clinical Decision Algorithm on Length of Hospital Stay and Costs of Care of Burned Patients

NCT03876340
completedphase_3

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

NCT00144508

Clinical Trials (4)

Showing 4 of 4 trials
NCT03666351Phase 4

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Completed
NCT02536898Not Applicable

Norwegian Capture the Fracture Initiative

Completed
NCT03876340Not Applicable

Impact of a Clinical Decision Algorithm on Length of Hospital Stay and Costs of Care of Burned Patients

Unknown
NCT00144508Phase 3

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

Completed

All 4 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
4